Hancock Whitney Corp Harmony Biosciences Holdings, Inc. Transaction History
Hancock Whitney Corp
- $2.88 Billion
- Q1 2024
A detailed history of Hancock Whitney Corp transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Hancock Whitney Corp holds 10,547 shares of HRMY stock, worth $316,410. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,547Holding current value
$316,410% of portfolio
0.01%Shares
3 transactions
Others Institutions Holding HRMY
# of Institutions
213Shares Held
44MCall Options Held
68.4KPut Options Held
52.1K-
Valor Management LLC Chicago, IL11.2MShares$337 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.92MShares$178 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.63MShares$109 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.61MShares$78.2 Million11.71% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.49MShares$74.8 Million0.22% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $1.77B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...